Ntracts is the trusted contract management partner for healthcare organizations. We deliver a comprehensive contract management solution through a unique combination of healthcare, technical, and legal expertise matched with a user input-driven online tool that mitigates compliance risk, achieves cost savings, improves efficiency, and ensures healthcare organizations stay in front of changing regulations.
Membership in the Ntracts Advisory Council offers Nancy Ardell the opportunity to connect with like-minded individuals dedicated to enhancing contract management and healthcare IT for departmental optimization. It’s both enjoyable and constructive, as the open exchange of ideas among a supportive group contributes to collective improvement and shared success.
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…